Mouse Anti-AML scFv-Fc Chimera (VS-0125-FY111)

CAT#: VS-0125-FY111

The antibody product is a recombinant scFv-Fc antibody, which is a fusion antibody that combines a specific scFv region highly specific to acute myeloid leukemia (AML) cells. By fusing the scFv region with the Fc fragment of the IgG2a mouse antibody, this antibody is able not only to target and bind to AML cells but also to extend its half-life in vivo, thereby improving therapeutic efficacy. Additionally, the design of this structure enhances the cellular immune activity of the antibody, which may help to more effectively recruit and activate the immune system against tumor cells.

Specifications

  • Host Species
  • Mouse
  • Type
  • Mouse IgG2a, scFv-Fc
  • Species Reactivity
  • Human
  • Applications
  • Bioimaging
  • Related Disease
  • Acute myeloid leukemia (AML)

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Format
  • Liquid
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Stabilizer
  • No Stabilizers
  • Sterility
  • 0.2 μM filtered
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • scFv-Fc antibodies have multiple important functions, primarily including specific binding, internalization, and serving as candidates for immunoconjugates. They are capable of specifically binding to acute myeloid leukemia (AML) cells, which imparts potential value for both diagnosis and treatment. Furthermore, these antibodies can be internalized by AML blast cells, allowing for accurate targeting of the cells and potentially serving as drug delivery vectors. By conjugating with drugs or probes, scFv-Fc antibodies can become crucial tools for targeted therapy and imaging, further enhancing the efficacy and precision of treatments.

Target

  • Alternative Names
  • Acute Myeloid Leukemia; AML
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0125-FY111. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Secondary Antibody

See other products for "AML"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-60 Recombinant Anti-human AML Antibody WB, Dot, FuncS IgG
MHH-60 Recombinant Human Anti-human AML Antibody ELISA, WB, FuncS IgG
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare